Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acetyl-CoA carboxylase
(
ACC
) is the rate-limiting enzyme in the biogenesis of long chain fatty acids. The phosphorylation of the Ser-1200 residue by cyclic AMP-dependent protein kinase transforms
ACC
from a citrate-independent form to a citrate-dependent form (10, 16). We have isolated
ACC
cDNA clones with and without 24 bases which code for 8 additional amino acids located 4 residues upstream to the Ser-1200. The presence of the 8 extra amino acids inhibits the in vitro phosphorylation of the Ser-1200 by the catalytic subunit of cyclic AMP-dependent protein kinase. The
S1 nuclease
protection experiments indicate that the corresponding two
ACC
mRNA species occur in vivo. Furthermore, the occurrence of the two forms of
ACC
mRNA is regulated under different physiological conditions for lipogenesis in a tissue-specific manner. The existence of two forms of
ACC
mRNA provides the basis for the existence of isozymes of
ACC
whose Ser-1200 can be selectively phosphorylated. The location of this regulatory sequence for a specific phosphorylation site represents a new regulatory mechanism for protein phosphorylation.
...
PMID:Acetyl-CoA carboxylase mRNA species with or without inhibitory coding sequence for Ser-1200 phosphorylation. 197 51